Bill Cara’s Blog: March 18, 2017
  • March 18, 2017 02:38 pm
  • by Bill Cara

The Importance of Stem Cell Science

Without exaggeration, the science of stem cells regenerative medicine is the most important science of our time. Some experts say that it is at least as important as the Internet. As part of our new approach to information on this website, we are going to post a daily performance summary of most of the stem cell companies that are publicly traded.

Here is the list as well as the exchanges the stocks trade on and the type of business that is the primary focus of each company.


In time, you will find, via the MARKETS tab, the links to the company profiles, stock charts, and, for US registered securities, the SEC filings including the Management Discussion & Analysis.

The plain truth is that many of these companies will end up as business failures. Before they crash, those that are doomed will flood the market with hyped news releases and magazine articles that indicate a glowing future. Caveat Emptor. Do not overlook the SEC filings!

Since I have associates who can provide me a research capability that will be more objective than what I expect to obtain from the companies themselves, I will write blogs, infrequently but where I think I might be helpful. Hopefully we can develop a dialog here about this important subject.

A friend of mine whom is well known to investors who are interested in Goldminers is Rob McEwen, a philanthropist who has donated tens of millions to the advancement of stem cell science. The McEwen Centre for Regenerative Medicine at Toronto General Hospital is a part of his legacy.

This is important to me and, I hope, to you.

Enjoy your weekend.


Like to give your opinion? Go to Comments


Disclaimer: is a website published by Greenfield Capital Inc and neither Greenfield Capital nor is a registered broker-dealer or a registered investment adviser. You understand that this web site and its content is furnished for non-commercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold that or any other security, nor any particular portfolio of securities, transaction or investment strategy as suitable for any specific person. Information regarding trading and investment as provided by this website is not tailored to the investment needs of any specific person. Greenfield Capital and services will not advise you personally concerning the nature, potential, value or suitability of any particular security, securities portfolio, transaction or other matter. You acknowledge that you are responsible for your own financial decisions and should seek a registered agent depending on your own risk tolerance to advise you on your personal trading activities.